Niuminco EBITDA margin
What is the EBITDA margin of Niuminco?
The EBITDA margin of Niuminco Group Limited is -383.18%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Materials sector on ASX compared to Niuminco
What does Niuminco do?
Niuminco Group Limited, through its subsidiaries, engages in the exploration and evaluation of mineral properties. The company primarily explores for gold, silver, and copper deposits. It holds a 100% interest in the May River and Bolobip exploration licenses; and the Edie Creek mining leases located in Papua New Guinea. The company was incorporated in 2006 and is based in Belrose, Australia.
Companies with ebitda margin similar to Niuminco
- Wrap Technologies has EBITDA margin of -387.37%
- Concurrent Computer has EBITDA margin of -384.81%
- CCUR has EBITDA margin of -384.81%
- Nagambie Resources has EBITDA margin of -384.51%
- OSE Immunotherapeutics SA has EBITDA margin of -383.51%
- Northern Minerals has EBITDA margin of -383.45%
- Niuminco has EBITDA margin of -383.18%
- INVO Bioscience has EBITDA margin of -383.06%
- Alterra has EBITDA margin of -382.96%
- Adamis Pharmaceuticals Corp has EBITDA margin of -382.23%
- Voluntis S.A has EBITDA margin of -379.54%
- Evgen Pharma plc has EBITDA margin of -379.12%
- American Resources has EBITDA margin of -378.54%